Recruiting
Phase 2

Sponsor:

Gilead Sciences

Code:

NCT05629208

Conditions

Cutaneous Lupus Erythematosus (CLE)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Edecesertib

Edecesertib Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-01. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2025-03-26.